Home » News » Stocks New York: Strong month ends with profit-taking | 11/30/20

Stocks New York: Strong month ends with profit-taking | 11/30/20

NEW YORK (dpa-AFX) – At the end of a strong month, investors take profits on Wall Street on Monday. The leading index Dow Jones Industrial (Dow Jones 30 Industrial) fell by 1.21 percent to 29,549.80 points two hours before the end. This moved him further away from the 30,000 point mark that he had left behind for the first time the previous week. In these spheres, investors had recently got cold feet again.

What remains is a strong November. First shaped by the US election and then even stronger on the vaccine news, the Dow is up 11.5 percent so far this month. Since Biontech and Pfizer fueled the first euphoria on November 9, the annual balance for the leading index has also become positive again. Regardless of the virus crisis, a Dow gain of 3.5 percent is currently emerging for the Corona year 2020.

With the leading Wall Street index, the other New York indices were also in reverse on Monday, albeit less clearly than the Dow. The market-wide S&P 500 fell 0.69 percent to 3,613.30 points, while the tech-heavy NASDAQ 100 fell 0.17 percent to 12,236.98 points. The weighty Apple share with a price increase of 2.6 percent was seen as a support here.

At the beginning of the week, the focus was once again on the developers of corona vaccines – with a broad rally that also took hold of the Novavax shares, despite what appears to be bad news. Here the papers advanced by a further ten percent, even if the company announced a delay of several weeks in the decisive study for its own vaccine candidate.

However, unlike corporations such as Moderna, BioNTech or CureVac, Novavax is still a bit away from course records. Their shares were on Monday with price jumps between eleven percent and 16 percent more expensive than ever. Moderna had announced that approval for a corona vaccine in the EU should be applied for this Monday. At Biontech, there is now speculation about a very quick approval in Great Britain.

Aside from the coronavirus situation, the prospect of takeovers heated tempers. S&P Global wants to take over competitor IHS Markit in a 44 billion US dollar share deal. While the Markit titles gained about seven percent, those from S&P Global brought it up 1.7 percent.

Meanwhile, a possible Salesforce bid for Slack also provides further topics of conversation. A plus of 5.7 percent catapulted them over the previous record of 42 dollars, which came from the day of the IPO in June 2019. As the business broadcaster CNBC reported, citing circles, an offer could come on Tuesday. For Salesforce stocks, the Dow then fell 3.1 percent to its lowest level since early November.

The next record was also set by the electric car maker Tesla, whose shares jumped above the $ 600 mark for the first time since their share split in August. But then profit-taking began, most recently the papers were traded at just under one percent in the red.

Nikola papers, on the other hand, collapsed by a quarter. That acted as a Tesla competitor Electric car-Start-Up had admitted that General Motors would not initially be involved. The GM shares fell 1.7 percent.

Otherwise, oil values ​​came under heavy pressure with the falling oil price. Exchange rate losses between 3.0 and 4.7 percent at the industry giants ExxonMobil, Chevron and ConocoPhillips were linked to the fact that there were media reports about a disagreement in the oil network Opec./tih/he

TRADE FOREIGN EXCHANGE WITH UP TO LEVER 30 NOW

Trade forex with high leverage and small spreads. With only € 100.00 you can benefit from the effect of € 3,000 in capital.

76.4% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford the high risk of losing your money.


– .

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.